What's in Fondazione Ricerca Traslazionale's pipeline?

Fondazione Ricerca Traslazionale has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Fondazione Ricerca Traslazionale's portfolio?

Top competitors by shared drug class: AbbVie, AbbVie (prior sponsor, Abbott), AstraZeneca, BeiGene, Clovis Oncology, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fondazione-ricerca-traslazionale.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Fondazione Ricerca Traslazionale — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fondazione Ricerca Traslazionale pipeline: 0 marketed, 0 filed, 1 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Olaparib tablet	Olaparib tablet	phase 3	PARP inhibitor	PARP1, PARP2	Oncology

Therapeutic area mix

Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
AbbVie (prior sponsor, Abbott) · 1 shared drug class
AstraZeneca · 1 shared drug class
BeiGene · 1 shared drug class
Clovis Oncology, Inc. · 1 shared drug class
GERCOR - Multidisciplinary Oncology Cooperative Group · 1 shared drug class
Hospices Civils de Lyon · 1 shared drug class
Pfizer Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fondazione Ricerca Traslazionale:

Cite this brief

Drug Landscape (2026). Fondazione Ricerca Traslazionale — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fondazione-ricerca-traslazionale. Accessed 2026-05-16.